$6.52 Billion is the total value of Eventide Asset Management's 158 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 32.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $284,218,000 | +7.7% | 1,704,148 | -0.3% | 4.36% | -15.6% |
| EXAS | EXACT SCIENCES CORP | $230,533,000 | +30.0% | 1,740,000 | 0.0% | 3.54% | +1.8% | |
| TTD | Sell | THE TRADE DESK INC | $217,646,000 | +39.2% | 271,718 | -9.9% | 3.34% | +9.0% |
| CRWD | Buy | CROWDSTRIKE HLDGS INCcl a | $212,304,000 | +55.4% | 1,002,285 | +0.8% | 3.26% | +21.8% |
| FIVN | Buy | FIVE9 INC | $203,920,000 | +35.7% | 1,169,268 | +0.9% | 3.13% | +6.3% |
| PRAX | New | PRAXIS PRECISION MEDICINES I | $183,766,000 | – | 3,513,081 | +100.0% | 2.82% | – |
| SRPT | SAREPTA THERAPEUTICS INC | $158,813,000 | +21.4% | 931,512 | 0.0% | 2.44% | -4.9% | |
| BHVN | BIOHAVEN PHARMACTL HLDG CO L | $152,886,000 | +31.8% | 1,783,761 | 0.0% | 2.34% | +3.3% | |
| TWLO | Buy | TWILIO INCcl a | $132,384,000 | +38.1% | 391,090 | +0.8% | 2.03% | +8.2% |
| ROP | Buy | ROPER TECHNOLOGIES INC | $132,000,000 | +31.9% | 306,200 | +20.9% | 2.02% | +3.4% |
| IDXX | Buy | IDEXX LABS INC | $119,969,000 | +51.8% | 240,000 | +19.4% | 1.84% | +18.9% |
| DT | Buy | DYNATRACE INC | $117,435,000 | +8.2% | 2,714,008 | +2.6% | 1.80% | -15.2% |
| MTD | Buy | METTLER TOLEDO INTERNATIONAL | $117,387,000 | +33.6% | 103,000 | +13.2% | 1.80% | +4.7% |
| FVRR | Buy | FIVERR INTL LTD | $102,812,000 | +43.1% | 526,971 | +1.9% | 1.58% | +12.2% |
| LRCX | Buy | LAM RESEARCH CORP | $96,381,000 | +44.0% | 204,081 | +1.1% | 1.48% | +12.7% |
| HUBS | Buy | HUBSPOT INC | $93,951,000 | +36.4% | 236,987 | +0.6% | 1.44% | +6.9% |
| POOL | Buy | POOL CORP | $93,795,000 | +12.2% | 251,800 | +0.8% | 1.44% | -12.1% |
| KRTX | KARUNA THERAPEUTICS INC | $91,540,000 | +31.4% | 901,077 | 0.0% | 1.40% | +2.9% | |
| ZI | Buy | ZOOMINFO TECHNOLOGIES INC | $91,582,000 | +104.1% | 1,898,851 | +81.9% | 1.40% | +59.7% |
| W | Sell | WAYFAIR INCcl a | $90,776,000 | -45.9% | 402,000 | -30.2% | 1.39% | -57.6% |
| NEP | Buy | NEXTERA ENERGY PARTNERS LP | $89,525,000 | +17.1% | 1,335,200 | +4.7% | 1.37% | -8.3% |
| TT | Buy | TRANE TECHNOLOGIES PLC | $88,127,000 | +23.2% | 607,100 | +2.9% | 1.35% | -3.5% |
| VRSK | Buy | VERISK ANALYTICS INC | $87,042,000 | +40.9% | 419,300 | +25.8% | 1.34% | +10.4% |
| LOW | Buy | LOWES COS INC | $84,476,000 | -1.0% | 526,300 | +2.3% | 1.30% | -22.5% |
| ASML | ASML HOLDING N V | $83,888,000 | +32.1% | 172,000 | 0.0% | 1.29% | +3.5% | |
| WCN | WASTE CONNECTIONS INC | $82,466,000 | -1.2% | 804,000 | 0.0% | 1.26% | -22.6% | |
| RNG | Buy | RINGCENTRAL INCcl a | $81,819,000 | +87.0% | 215,898 | +35.5% | 1.26% | +46.4% |
| TREX | TREX CO INC | $73,841,000 | +16.9% | 882,000 | 0.0% | 1.13% | -8.4% | |
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $71,039,000 | +112.3% | 583,000 | +52.2% | 1.09% | +66.3% |
| ODFL | Buy | OLD DOMINION FREIGHT LINE IN | $71,046,000 | +10.1% | 364,000 | +2.1% | 1.09% | -13.8% |
| Buy | TRILLIUM THERAPEUTICS INC | $70,335,000 | +54.8% | 4,781,448 | +49.6% | 1.08% | +21.4% | |
| APTV | APTIV PLC | $69,966,000 | +42.1% | 537,000 | 0.0% | 1.07% | +11.3% | |
| PLRX | PLIANT THERAPEUTICS INC | $64,482,000 | +4.5% | 2,838,125 | 0.0% | 0.99% | -18.1% | |
| CTAS | Buy | CINTAS CORP | $63,269,000 | +42.9% | 179,000 | +34.6% | 0.97% | +11.9% |
| MGA | Buy | MAGNA INTL INC | $56,874,000 | +56.7% | 803,300 | +1.3% | 0.87% | +22.8% |
| BEP | Buy | BROOKFIELD RENEWABLE PARTNERpartnership unit | $53,333,000 | +14.4% | 1,236,000 | +39.3% | 0.82% | -10.4% |
| HASI | Buy | HANNON ARMSTRONG SUST INFR C | $52,786,000 | +51.0% | 832,200 | +0.6% | 0.81% | +18.3% |
| PANW | Buy | PALO ALTO NETWORKS INC | $52,784,000 | +48.4% | 148,523 | +2.2% | 0.81% | +16.2% |
| DHI | Buy | D R HORTON INC | $52,365,000 | -3.8% | 759,800 | +5.6% | 0.80% | -24.6% |
| VITL | New | VITAL FARMS INC | $51,967,000 | – | 2,053,232 | +100.0% | 0.80% | – |
| BPMC | BLUEPRINT MEDICINES CORP | $51,813,000 | +21.0% | 462,000 | 0.0% | 0.80% | -5.1% | |
| STRO | Buy | SUTRO BIOPHARMA INC | $51,474,000 | +157.9% | 2,370,975 | +19.4% | 0.79% | +101.8% |
| ECL | ECOLAB INC | $49,763,000 | +8.3% | 230,000 | 0.0% | 0.76% | -15.2% | |
| ANNX | Buy | ANNEXON INC | $49,177,000 | -6.1% | 2,004,616 | +13.1% | 0.75% | -26.5% |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $48,632,000 | -3.8% | 2,427,976 | 0.0% | 0.75% | -24.6% | |
| YETI | New | YETI HLDGS INC | $47,244,000 | – | 690,000 | +100.0% | 0.72% | – |
| ARGX | ARGENX SEsponsored adr | $47,054,000 | +12.0% | 160,000 | 0.0% | 0.72% | -12.2% | |
| SPT | Buy | SPROUT SOCIAL INC | $46,088,000 | +22.2% | 1,014,920 | +3.6% | 0.71% | -4.3% |
| DDOG | Buy | DATADOG INC | $46,011,000 | +34.3% | 467,403 | +39.4% | 0.71% | +5.2% |
| VCYT | VERACYTE INC | $45,514,000 | +50.6% | 930,000 | 0.0% | 0.70% | +18.1% | |
| ALLK | Buy | ALLAKOS INC | $44,380,000 | +240.5% | 317,000 | +98.1% | 0.68% | +167.1% |
| FRLN | Buy | FREELINE THERAPEUTICS HLDGSsponsored ads | $44,266,000 | +24.3% | 2,485,656 | +6.1% | 0.68% | -2.6% |
| CCI | Buy | CROWN CASTLE INTL CORP NEW | $44,159,000 | -2.2% | 277,400 | +2.2% | 0.68% | -23.4% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $43,279,000 | +319.4% | 1,946,000 | +178.3% | 0.66% | +228.7% |
| ZNTL | Sell | ZENTALIS PHARMACEUTICALS INC | $43,214,000 | +49.9% | 832,000 | -8.7% | 0.66% | +17.6% |
| IMVT | IMMUNOVANT INC | $43,049,000 | +31.3% | 932,000 | 0.0% | 0.66% | +2.8% | |
| EIDX | EIDOS THERAPEUTICS INC | $41,766,000 | +160.4% | 317,417 | 0.0% | 0.64% | +103.8% | |
| CWEN | Buy | CLEARWAY ENERGY INCcl c | $39,826,000 | +884.1% | 1,247,300 | +731.0% | 0.61% | +673.4% |
| EDIT | New | EDITAS MEDICINE INCput | $37,954,000 | – | 583,900 | +100.0% | 0.58% | – |
| KURA | Buy | KURA ONCOLOGY INC | $34,620,000 | +182.5% | 1,060,000 | +165.0% | 0.53% | +121.2% |
| NRIX | Buy | NURIX THERAPEUTICS INC | $34,524,000 | +98.7% | 1,050,000 | +111.0% | 0.53% | +55.6% |
| ADCT | Buy | ADC THERAPEUTICS SA | $34,411,000 | +79.7% | 1,075,000 | +85.2% | 0.53% | +40.8% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $33,835,000 | -2.3% | 353,000 | -2.0% | 0.52% | -23.5% |
| NOVT | Sell | NOVANTA INC | $33,102,000 | +11.2% | 280,000 | -0.9% | 0.51% | -12.9% |
| GNRC | New | GENERAC HLDGS INC | $32,520,000 | – | 143,000 | +100.0% | 0.50% | – |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $32,186,000 | +328.7% | 1,837,108 | +262.9% | 0.49% | +236.1% |
| MDB | Buy | MONGODB INCcl a | $31,947,000 | +57.2% | 88,980 | +1.3% | 0.49% | +23.1% |
| KALV | KALVISTA PHARMACEUTICALS INC | $31,903,000 | +50.8% | 1,680,000 | 0.0% | 0.49% | +18.1% | |
| NTLA | New | INTELLIA THERAPEUTICS INCput | $30,327,000 | – | 551,400 | +100.0% | 0.46% | – |
| SMAR | SMARTSHEET INC | $30,280,000 | +40.2% | 437,000 | 0.0% | 0.46% | +9.7% | |
| CGNX | COGNEX CORP | $28,822,000 | +23.3% | 359,000 | 0.0% | 0.44% | -3.3% | |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $28,437,000 | -43.1% | 129,471 | -57.0% | 0.44% | -55.4% |
| ROL | Buy | ROLLINS INC | $28,423,000 | +8.1% | 727,500 | +50.0% | 0.44% | -15.2% |
| SWKS | Buy | SKYWORKS SOLUTIONS INC | $27,602,000 | +20.1% | 180,547 | +14.3% | 0.42% | -6.0% |
| OKTA | OKTA INCcl a | $27,460,000 | +18.9% | 108,000 | 0.0% | 0.42% | -6.9% | |
| BEPC | Buy | BROOKFIELD RENEWABLE CORPcl a sub vtg | $27,235,000 | +63.0% | 467,400 | +63.9% | 0.42% | +27.8% |
| MPWR | Buy | MONOLITHIC PWR SYS INC | $26,683,000 | +34.5% | 72,859 | +2.7% | 0.41% | +5.4% |
| EPIX | ESSA PHARMA INC | $26,466,000 | +72.9% | 2,335,169 | 0.0% | 0.41% | +35.3% | |
| XPO | XPO LOGISTICS INC | $26,224,000 | +40.8% | 220,000 | 0.0% | 0.40% | +10.1% | |
| LII | LENNOX INTL INC | $26,027,000 | +0.5% | 95,000 | 0.0% | 0.40% | -21.3% | |
| KROS | New | KEROS THERAPEUTICS INC | $24,407,000 | – | 346,000 | +100.0% | 0.37% | – |
| CCXI | Buy | CHEMOCENTRYX INC | $23,963,000 | +47.2% | 387,000 | +30.3% | 0.37% | +15.0% |
| SHC | New | SOTERA HEALTH CO | $23,873,000 | – | 870,000 | +100.0% | 0.37% | – |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $23,774,000 | -44.0% | 206,000 | -52.8% | 0.36% | -56.1% |
| KALA | KALA PHARMACEUTICALS INC | $23,391,000 | -9.6% | 3,450,000 | 0.0% | 0.36% | -29.2% | |
| RGEN | REPLIGEN CORP | $22,804,000 | +29.9% | 119,000 | 0.0% | 0.35% | +1.7% | |
| XNCR | Buy | XENCOR INC | $22,077,000 | +89.7% | 506,000 | +68.7% | 0.34% | +48.7% |
| LGVW | New | LONGVIEW ACQUISITION CORP | $22,125,000 | – | 1,118,000 | +100.0% | 0.34% | – |
| ETNB | Buy | 89BIO INC | $21,178,000 | +22.3% | 869,000 | +28.7% | 0.32% | -4.1% |
| ISRG | INTUITIVE SURGICAL INC | $20,452,000 | +15.3% | 25,000 | 0.0% | 0.31% | -9.5% | |
| PHAT | Buy | PHATHOM PHARMACEUTICALS INC | $19,932,000 | +20.8% | 600,000 | +33.3% | 0.31% | -5.3% |
| MASS | New | 908 DEVICES INC | $18,980,000 | – | 333,283 | +100.0% | 0.29% | – |
| XLRN | ACCELERON PHARMA INC | $18,283,000 | +13.7% | 142,900 | 0.0% | 0.28% | -11.1% | |
| AVRO | Sell | AVROBIO INC | $18,196,000 | -26.6% | 1,305,307 | -31.5% | 0.28% | -42.6% |
| SGEN | New | SEAGEN INC | $17,952,000 | – | 102,500 | +100.0% | 0.28% | – |
| LW | LAMB WESTON HLDGS INC | $15,984,000 | +18.8% | 203,000 | 0.0% | 0.24% | -6.8% | |
| XENE | Sell | XENON PHARMACEUTICALS INC | $15,844,000 | +12.3% | 1,030,140 | -19.1% | 0.24% | -12.0% |
| SBTX | New | SILVERBACK THERAPEUTICS INC | $15,824,000 | – | 341,473 | +100.0% | 0.24% | – |
| REGN | REGENERON PHARMACEUTICALS | $14,928,000 | -13.7% | 30,900 | 0.0% | 0.23% | -32.4% | |
| ORIC | New | ORIC PHARMACEUTICALS INC | $14,556,000 | – | 430,000 | +100.0% | 0.22% | – |
| CIEN | CIENA CORP | $14,111,000 | +33.2% | 267,000 | 0.0% | 0.22% | +4.3% | |
| DCPH | DECIPHERA PHARMACEUTICALS IN | $13,868,000 | +11.2% | 243,000 | 0.0% | 0.21% | -12.7% | |
| CHMA | CHIASMA INC | $13,051,000 | +1.2% | 3,000,326 | 0.0% | 0.20% | -20.9% | |
| MKC | Buy | MCCORMICK & CO INC | $12,317,000 | +1.4% | 128,840 | +105.8% | 0.19% | -20.6% |
| ABCL | New | ABCELLERA BIOLOGICS INC | $12,072,000 | – | 300,000 | +100.0% | 0.18% | – |
| GLPG | Buy | GALAPAGOS NVspon adr | $11,086,000 | +53.2% | 112,000 | +119.6% | 0.17% | +19.7% |
| A | Buy | AGILENT TECHNOLOGIES INC | $10,960,000 | +47.9% | 92,500 | +26.0% | 0.17% | +15.9% |
| New | APTOSE BIOSCIENCES INC | $10,070,000 | – | 2,299,000 | +100.0% | 0.15% | – | |
| FRC | Buy | FIRST REP BK SAN FRANCISCO C | $9,448,000 | +121.0% | 64,300 | +64.0% | 0.14% | +72.6% |
| ITT | Buy | ITT INC | $9,073,000 | +51.7% | 117,800 | +16.3% | 0.14% | +18.8% |
| PLD | Buy | PROLOGIS INC. | $9,079,000 | +18.0% | 91,100 | +19.1% | 0.14% | -7.9% |
| FHN | Buy | FIRST HORIZON CORPORATION | $8,852,000 | +331.0% | 693,700 | +218.5% | 0.14% | +240.0% |
| IMTX | IMMATICS N.V | $8,632,000 | +1.7% | 800,000 | 0.0% | 0.13% | -20.5% | |
| FENC | FENNEC PHARMACEUTICALS INC | $8,344,000 | +22.9% | 1,120,000 | 0.0% | 0.13% | -3.8% | |
| MGTA | Sell | MAGENTA THERAPEUTICS INC | $7,840,000 | -51.1% | 1,000,000 | -57.6% | 0.12% | -61.8% |
| ENTG | Buy | ENTEGRIS INC | $7,460,000 | +69.9% | 77,629 | +31.4% | 0.11% | +32.6% |
| KNTE | New | KINNATE BIOPHARMA INC | $6,962,000 | – | 175,000 | +100.0% | 0.11% | – |
| KLAC | Buy | KLA CORP | $6,602,000 | +52.3% | 25,498 | +14.0% | 0.10% | +18.8% |
| JKHY | Buy | HENRY JACK & ASSOC INC | $6,501,000 | +50.9% | 40,132 | +51.4% | 0.10% | +19.0% |
| New | PALO ALTO NETWORKS INCnote 0.750% 7/0 | $6,124,000 | – | 4,334,000 | +100.0% | 0.09% | – | |
| STE | Buy | STERIS PLC | $5,999,000 | +16.6% | 31,650 | +8.4% | 0.09% | -8.9% |
| ARE | Sell | ALEXANDRIA REAL ESTATE EQ IN | $5,757,000 | -3.0% | 32,300 | -12.9% | 0.09% | -24.1% |
| CRNX | Sell | CRINETICS PHARMACEUTICALS IN | $5,644,000 | -73.3% | 400,000 | -70.3% | 0.09% | -78.9% |
| PNR | New | PENTAIR PLC | $5,314,000 | – | 100,100 | +100.0% | 0.08% | – |
| SBAC | New | SBA COMMUNICATIONS CORP NEWcl a | $4,928,000 | – | 17,466 | +100.0% | 0.08% | – |
| EXACT SCIENCES CORPnote 1.000% 1/1 | $4,578,000 | +22.3% | 2,411,000 | 0.0% | 0.07% | -4.1% | ||
| SNPS | Buy | SYNOPSYS INC | $4,487,000 | +127.0% | 17,309 | +87.4% | 0.07% | +76.9% |
| AWK | AMERICAN WATER WORKS CO INC | $4,435,000 | +5.9% | 28,900 | 0.0% | 0.07% | -17.1% | |
| SYY | Buy | SYSCO CORP | $4,084,000 | +77.9% | 55,000 | +49.1% | 0.06% | +40.0% |
| ZTS | Buy | ZOETIS INCcl a | $3,674,000 | +26.2% | 22,200 | +26.1% | 0.06% | -1.8% |
| Buy | NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1 | $3,570,000 | +20.5% | 2,569,000 | +20.1% | 0.06% | -5.2% | |
| IEX | Buy | IDEX CORP | $3,491,000 | +73.9% | 17,524 | +59.3% | 0.05% | +38.5% |
| SBNY | New | SIGNATURE BK NEW YORK N Y | $3,504,000 | – | 25,900 | +100.0% | 0.05% | – |
| MSCI | Buy | MSCI INC | $3,193,000 | +98.8% | 7,150 | +58.9% | 0.05% | +58.1% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $3,116,000 | -17.7% | 20,220 | -27.3% | 0.05% | -35.1% |
| SHW | Sell | SHERWIN WILLIAMS CO | $3,087,000 | -17.9% | 4,200 | -22.2% | 0.05% | -36.5% |
| NXPI | New | NXP SEMICONDUCTORS N V | $2,894,000 | – | 18,200 | +100.0% | 0.04% | – |
| AMWL | AMERICAN WELL CORPcl a | $2,789,000 | -14.5% | 110,091 | 0.0% | 0.04% | -32.8% | |
| TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $2,813,000 | +90.7% | 25,800 | +41.8% | 0.04% | +48.3% |
| GRMN | New | GARMIN LTD | $2,501,000 | – | 20,900 | +100.0% | 0.04% | – |
| NDAQ | New | NASDAQ INC | $2,496,000 | – | 18,800 | +100.0% | 0.04% | – |
| FOUR | New | SHIFT4 PMTS INCcl a | $2,402,000 | – | 31,860 | +100.0% | 0.04% | – |
| MAX | New | MEDIAALPHA INCcl a added | $2,407,000 | – | 61,611 | +100.0% | 0.04% | – |
| ETTX | ENTASIS THERAPEUTICS HLDGS I | $2,064,000 | +21.1% | 879,541 | 0.0% | 0.03% | -3.0% | |
| VFC | New | V F CORP | $2,016,000 | – | 23,600 | +100.0% | 0.03% | – |
| AMD | Buy | ADVANCED MICRO DEVICES INC | $1,882,000 | +458.5% | 20,524 | +399.6% | 0.03% | +314.3% |
| EQIX | Sell | EQUINIX INC | $1,800,000 | -49.6% | 2,520 | -46.4% | 0.03% | -60.0% |
| FATE | New | FATE THERAPEUTICS INCput | $1,796,000 | – | 18,900 | +100.0% | 0.03% | – |
| LSCC | Buy | LATTICE SEMICONDUCTOR CORP | $1,601,000 | +128.7% | 34,944 | +44.6% | 0.02% | +78.6% |
| OM | Buy | OUTSET MED INC | $1,491,000 | +118.6% | 26,237 | +92.4% | 0.02% | +76.9% |
| IMTXW | IMMATICS N.V*w exp 07/01/202 | $1,152,000 | -16.5% | 400,000 | 0.0% | 0.02% | -33.3% | |
| DPZ | Sell | DOMINOS PIZZA INC | $1,193,000 | -40.3% | 3,110 | -33.8% | 0.02% | -53.8% |
| SLAB | Buy | SILICON LABORATORIES INC | $1,171,000 | +174.2% | 9,198 | +110.6% | 0.02% | +125.0% |
| DOCU | Buy | DOCUSIGN INC | $1,071,000 | +70.0% | 4,819 | +64.8% | 0.02% | +33.3% |
| LMND | New | LEMONADE INCput | $935,000 | – | 17,000 | +100.0% | 0.01% | – |
| NEWR | New | NEW RELIC INCput | $660,000 | – | 12,000 | +100.0% | 0.01% | – |
| AMWL | New | AMERICAN WELL CORPput | $525,000 | – | 21,000 | +100.0% | 0.01% | – |
| APPN | New | APPIAN CORPput | $375,000 | – | 3,000 | +100.0% | 0.01% | – |
| OSH | Exit | OAK STR HEALTH INC | $0 | – | -5,000 | -100.0% | -0.01% | – |
| WM | Exit | WASTE MGMT INC DEL | $0 | – | -20,500 | -100.0% | -0.04% | – |
| NEE | Exit | NEXTERA ENERGY INC | $0 | – | -18,500 | -100.0% | -0.10% | – |
| ARVN | Exit | ARVINAS INC | $0 | – | -230,000 | -100.0% | -0.11% | – |
| RLAY | Exit | RELAY THERAPEUTICS INC | $0 | – | -250,000 | -100.0% | -0.21% | – |
| JAMF | Exit | JAMF HLDG CORP | $0 | – | -430,000 | -100.0% | -0.32% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -102,500 | -100.0% | -0.39% | – |
| AY | Exit | ATLANTICA SUSTAINABLE INFR P | $0 | – | -736,000 | -100.0% | -0.41% | – |
| VMC | Exit | VULCAN MATLS CO | $0 | – | -187,000 | -100.0% | -0.50% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -535,000 | -100.0% | -0.58% | – |
| SPLK | Exit | SPLUNK INC | $0 | – | -181,237 | -100.0% | -0.67% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -1,550,000 | -100.0% | -0.69% | – |
| IPHI | Exit | INPHI CORP | $0 | – | -454,378 | -100.0% | -1.00% | – |
| MYOK | Exit | MYOKARDIA INC | $0 | – | -621,000 | -100.0% | -1.66% | – |
| IGV | Exit | ISHARES TRput | $0 | – | -480,000 | -100.0% | -2.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 43 | Q2 2024 | 3.2% |
| PALO ALTO NETWORKS INC | 43 | Q2 2024 | 3.6% |
| ASML HOLDINGS NV | 43 | Q2 2024 | 1.9% |
| REPLIGEN CORP | 43 | Q2 2024 | 0.5% |
| VERACYTE INC | 41 | Q2 2024 | 1.5% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| LAM RESEARCH CORP | 38 | Q2 2024 | 3.4% |
| COLLEGIUM PHARMACEUTICAL INC | 37 | Q2 2024 | 2.6% |
| BLUEPRINT MEDICINES CORP | 36 | Q2 2024 | 1.3% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 908 Devices Inc. | February 14, 2024 | 1,430,995 | 4.4% |
| Annexon, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| Celldex Therapeutics, Inc. | February 14, 2024 | 3,630,013 | 6.6% |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2024 | 2,630,478 | 8.1% |
| Freeline Therapeutics Holdings plcSold out | February 14, 2024 | 0 | 0.0% |
| Inozyme Pharma, Inc. | February 14, 2024 | 3,179,837 | 5.2% |
| Korro Bio, Inc. | February 14, 2024 | 546,325 | 6.8% |
| MARINUS PHARMACEUTICALS, INC. | February 14, 2024 | 4,529,997 | 8.3% |
| Mirum Pharmaceuticals, Inc. | February 14, 2024 | 2,693,581 | 5.8% |
| Praxis Precision Medicines, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-27 |
| 13F-HR | 2024-08-13 |
| SC 13G/A | 2024-08-09 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.